Life sciences startup licenses Purdue technology to detect cancer cells

The founder of a life sciences startup that is commercializing a Purdue University innovation says a test to detect circulating tumor cells in a patient’s bloodstream could improve the chances of survival and quality of life.

Prof. Çağrı A. Savran, founder and manager of Savran Technologies, said there is only one test approved currently by the U.S. Food and Drug Administration to detect rare tumor cells.

Read article